[Retracted] TTC7B Is a Novel Prognostic‐Related Biomarker in Glioma Correlating with Immune Infiltrates and Response to Oxidative Stress by Temozolomide
- DOI
- 10.1155/2022/7595230
- Published
- 2022-01
- Container
- Oxidative Medicine and Cellular Longevity
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1155/2022/7595230,
title = {[Retracted] TTC7B Is a Novel Prognostic‐Related Biomarker in Glioma Correlating with Immune Infiltrates and Response to Oxidative Stress by Temozolomide},
author = {Zhenhua Chen and Shasha Cui and Yong Dai and Chunfeng Lu and Huan Zhang and Wei Zhao and Hongyan Yan and Yi Zhang},
year = {2022},
journal = {Oxidative Medicine and Cellular Longevity},
doi = {10.1155/2022/7595230},
url = {https://doi.org/10.1155/2022/7595230}
}RIS
TY - JOUR TI - [Retracted] TTC7B Is a Novel Prognostic‐Related Biomarker in Glioma Correlating with Immune Infiltrates and Response to Oxidative Stress by Temozolomide AU - Zhenhua Chen AU - Shasha Cui AU - Yong Dai AU - Chunfeng Lu AU - Huan Zhang AU - Wei Zhao AU - Hongyan Yan AU - Yi Zhang PY - 2022 JO - Oxidative Medicine and Cellular Longevity DO - 10.1155/2022/7595230 UR - https://doi.org/10.1155/2022/7595230 ER -
APA
Chen, Z., Cui, S., Dai, Y., Lu, C., Zhang, H., Zhao, W., Yan, H., & Zhang, Y. (2022). [Retracted] TTC7B Is a Novel Prognostic‐Related Biomarker in Glioma Correlating with Immune Infiltrates and Response to Oxidative Stress by Temozolomide. Oxidative Medicine and Cellular Longevity. https://doi.org/10.1155/2022/7595230
Source records
- crossref · retrieved 2026-09-25T09:07:05.599Z